NovoCure (NVCR) EBT (2014 - 2026)
NovoCure (NVCR) posted EBT of -$12.5 million for Q2 2026, up 82.02% sequentially from -$69.3 million in Q1 2026, and up 64.4% YoY from -$7.6 million in Q2 2025.
NovoCure (NVCR) EBT (2014 - 2026) Analysis & Trends
NovoCure has reported EBT for 13 years, with the latest figure at -$12.5 million in Q2 2026.
- Quarterly EBT rose 64.4% year-over-year to -$12.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$152.7 million (down 7.48% YoY) and the FY2025 annual result came in at -$136.2 million, down 3.88% from the prior year.
- EBT grew to -$12.5 million in Q2 2026 per NVCR's latest filing, from -$69.3 million in the prior quarter.
- Over five years, EBT peaked at -$2.5 million in Q1 2022 and troughed at -$69.3 million in Q1 2026.
- A 5-year average of -$34.6 million and a median of -$32.1 million in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2026: EBT plunged 1931.01% in 2023, then surged 64.4% in 2026.
- Over 5 years, EBT stood at -$32.6 million in 2022, then slipped by 18.35% to -$38.5 million in 2023, then plunged by 43.27% to -$55.2 million in 2024, then advanced by 25.82% to -$41.0 million in 2025, then soared by 69.6% to -$12.5 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$12.5 million, -$69.3 million, and -$41.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.52 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 1.56 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.06 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 519.80 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 317.50 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 693.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 855.50 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 273.50 Mn |
| 10 | NovoCure | 2.07 Bn | 1.63 Bn | 142.48 Mn | -12.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.45 Mn |
| Mar 31, 2026 | -69.26 Mn |
| Dec 31, 2025 | -40.95 Mn |
| Sep 30, 2025 | -30.02 Mn |
| Jun 30, 2025 | -34.98 Mn |
| Mar 31, 2025 | -30.30 Mn |
| Dec 31, 2024 | -55.21 Mn |
| Sep 30, 2024 | -21.59 Mn |
| Jun 30, 2024 | -22.73 Mn |
| Mar 31, 2024 | -31.64 Mn |
| Dec 31, 2023 | -38.53 Mn |
| Sep 30, 2023 | -48.22 Mn |
| Jun 30, 2023 | -53.90 Mn |
| Mar 31, 2023 | -51.08 Mn |
| Dec 31, 2022 | -32.56 Mn |
| Sep 30, 2022 | -23.42 Mn |
| Jun 30, 2022 | -23.36 Mn |
| Mar 31, 2022 | -2.52 Mn |
| Dec 31, 2021 | -25.57 Mn |
| Sep 30, 2021 | -10.53 Mn |